Table 3.
Multivariate analysis identifying HPV vaccine campaign target populations associated with “worry about getting the HPV infection”, “perception of the HPV vaccine as safe”, “perception of the access to get an HPV vaccine as easy”, “Knowledge of vaccine campaign targets in ER”, and HPV vaccine uptake.
| Worry About Getting the HPV Infection | Perception of the HPV Vaccine as Safe | Perception of the Access to Obtain an HPV Vaccine as Easy | Knowledge of Vaccine Campaign Targets in ER | Vaccine Uptake | |
|---|---|---|---|---|---|
| Age | 0.94 (0.91–0.98) * | 1.02 (0.95–1.10) | 1.05 (0.99–1.10) | 0.99 (0.96–1.02) | 1.03 (0.99–1.87) |
| Women ≤ 30 yo | 0.77 (0.26–2.27) | 1.66 (0.16–17.60) | 7.67 (0.88–66.74) | 0.43 (0.14–1.37) | 164.0 (17.2–1560.18) * |
| MSM | 1.47 (0.70–3.12) | 0.99 (0.26–3.81) | 0.77 (0.31–1.92) | 0.33 (0.15–0.70) * | 3.53 (1.37–9.11) * |
| PLHIV | 3.50 (0.81–15.10) | 0.16 (0.03–0.83) * | 2.29 (0.26–19.94) | 0.40 (0.10–1.59) | 3.62 (0.74–17.63) |
| Transgender | 1.34 (0.13–13.98) | 1 | 1.10 (0.10–12.48) | 0.89 (0.10–7.89) | 9.10 (0.70–118.04) |
* in bold the variables found to be statistically significant in the multivariate analysis performed.